Status:
UNKNOWN
Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease
Lead Sponsor:
University Medical Centre Ljubljana
Collaborating Sponsors:
University of Ljubljana, Faculty of Medicine
University Rehabilitation Institute, Republic of Slovenia
Conditions:
Acyanotic Congenital Heart Disease
Cyanotic Congenital Heart Disease
Eligibility:
All Genders
18+ years
Brief Summary
The aim of our study is to compare plasma metanephrines in patients with cyanotic and acyanotic congenital heart disease and possible association with chronic hypoxic stress.
Eligibility Criteria
Inclusion
- patients with congenital heart disease attending regular follow up
Exclusion
- missing main data in medical documentation
Key Trial Info
Start Date :
November 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 9 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04891081
Start Date
November 1 2019
End Date
June 9 2021
Last Update
May 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Ljubljana, Slovenia, 1000